Substituted aminopyrimidines as cholecystokinin-1 receptor modulators

Details for Australian Patent Application No. 2008209472 (hide)

Owner Merck & Co., Inc.

Inventors Edmondson, Scott; Sweis, Randy; Kaelin, David E.

Agent Spruson & Ferguson

Pub. Number AU-A-2008209472

PCT Pub. Number WO2008/091631

Priority 60/897,673 26.01.07 US

Filing date 22 January 2008

Wipo publication date 31 July 2008

International Classifications

A61K 31/505 (2006.01) - Pyrimidines

Event Publications

13 August 2009 PCT application entered the National Phase

  PCT publication WO2008/091631 Priority application(s): WO2008/091631

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008209473-A peptide composition and a method of promoting cartilage formation

2008209462-Gene expression profiling for identification, monitoring, and treatment of lupus erythematosus